Everolimus clinical trial

Timeframe: 2012 – 2014 Goal: Assess potential of treatment options for FLC Principal Investigator: Ghassan Abou-Alfa, MD, Memorial Sloan Kettering Cancer Center FCF funded the first clinical trial of drugs aimed specifically at fibrolamellar liver cancer.  The trial was also conducted at other consortium members, including the University of California San Francisco, Johns Hopkins, and Dana …

Read more